Anzeige
Erschienen in:
04.09.2017 | Original Paper
The AES total ankle arthroplasty analysis of failures and survivorship at ten years
Erschienen in: International Orthopaedics | Ausgabe 12/2017
Einloggen, um Zugang zu erhaltenAbstract
Background
AES mobile-bearing total ankle replacement was developed from the Buechel Pappas model. It was withdrawn in 2009, after identification of a higher than expected complication rate. The purpose of the current study was to analyse clinical outcomes, failures and survival of the initial series of 50 AES published in 2009.
Methods
In this single-centre continuous prospective study (2003–2006), 50 AES prostheses were included. Pre-operative osteoarthritis was mainly post-traumatic (50%) and secondary to instability (36%). All patients were assessed with clinical and radiographic follow-up at six months, one year, two years and every two to three years thereafter. A CT-scan was systematically performed before procedure, and at two years, five years and ten years. At last follow-up, all patients with TAR had a functional (SF 36, AOFAS) and clinical assessment. All complications or surgical events were analysed.
Results
The mean follow-up was ten ± two years (range, 9–13). The mean AOFAS score was 75 points (range, 26–100). The mean SF 36 score was 69 points (range, 35–97). There was a significant deterioration in AOFAS score at five years and at last follow-up (p < 0.05). Fifteen TARs underwent reoperation for cyst curettage–graft because of development of periprosthetic lesions. Six of them ended up with prosthesis removal–arthrodesis. At the last follow-up, 14 TARs were removed for arthrodesis. Of the 30 prostheses seen at last follow-up, four are awaiting prosthesis removal–arthrodesis and one for cyst curettage–graft. The ten year survivorships free of any prosthesis removal or arthrodesis and free of any reoperation were 68% (95% CI, 55–85) and 57% (95% CI, 44–74), respectively.
Conclusion
Our data suggested a high rate of reoperation. Overall ten year survival was lower than with other designs, particularly due to cyst lesions.
Level of evidence: Level IV, prospective case series